While Study 1 demonstrated a statistically significant reduction in knee OA pain with ReNu, Study 2 failed to meet its primary efficacy endpoint despite a numerical trend favoring the active treatment ...

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA Psychiatry.

The expanded indication lowers the eligible age from 12 to 2 years old for the autologous genome edited gene therapy following successful phase 3 trials in children. The Food and Drug Administration ...

Researchers evaluated whether corticosteroid treatment during acute SARS-CoV-2 infection decreases the risk for long COVID in pediatric patients.

Researchers evaluated whether accelerometer-derived sleep-wake characteristics can enhance dementia risk prediction models in older adults.

(HealthDay News) — Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting ...

The agency issued the orders to Swedish Match USA, Inc. after what it called an extensive scientific review. The company is a subsidiary of Philip Morris International. HealthDay News — The US Food ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.

Researchers discuss the potential neurologic effects of the menopausal transition on cognitive decline and multiple sclerosis ...

Patients with systemic lupus erythematosus (SLE) without lupus nephritis (LN) have increased risk of chronic kidney disease (CKD) and mortality, according to ...

At AANP 2026, clinicians share how NPs are on the front lines of asthma management, necessitating a full understanding of the ...

A clinical approach applying 3 distinct syndromes helps clinicians differentiate benign from catastrophic causes of vertigo, ...